Site Map
- Annual Reports
- Board of Directors
- Contact Us
- Corporate Sponsors
- Global Reach
- How MPN Research Foundation works
- How we make grants
- Meet Our Partners
- Mission
- MPN Research Foundation in the News
- Our Accreditations
- Our People
- Privacy Policy
- Scientific Advisory Board
- Sign up for alerts on PV, ET and MF
- Staff
- Strategy for 2013
- Terms of Use
- The audit process
- Why We Care
- Betty Kester Memorial Fund
- Beverly Weiss
- Billy Jerald Rainer
- Bronislaw Nowakowski
- Bruce Polcek
- Carol Hockman
- Caterina DiCesare
- Jim Spring
- Loretta Mae Sharp
- MPN Memorials
- Nancy Ann Sutter
- Paul Gerdes
- Planned Giving
- Support MPN Research Today
- To Discuss Contributing
- Wayman Siu
- Why Give
- William D. Grafton Jr.
- 2011 CMPD Conference
- 2012 MPN Midwest Symposium
- Al Bolea Memorial Bike Ride 2012
- Annette DeBow Trek for a Cure 2013
- Chicago Symposium 2012 flier
- Patient Reception Living with a Blood Cancer 2010
- Ruben Mesa is Tri-ing for a cure
- San Mateo Agenda
- San Mateo Presentations 2012
- UK MPN patient forum 2010
- Young female MPN patient meet-up
- Empower and Inform
- Feel the Need Feed the Cure
- Hosting Your Own Event
- Job Opportunities at MPNRF
- Make a Donation
- MF Challenge Research Initiative
- Participate in Clinical Trial
- Share Your Story
- Essential Thrombocythemia (ET)
- Glossary
- Learning About MPNs - PV, ET, PMF
- Links to Other Resources
- MDS and PV, ET, and MF
- Polycythemia Vera (PV)
- Primary Myelofibrosis (PMF)
- Scientific Publications on MPNs
- Video Updates
- Al Bolea Memorial Ride and BBQ Party
- Andy
- Bowling for Blood Cancer
- Calendar
- Community & Scientific Events
- Delaney ET
- Find a Treatment Facility
- Frances - ET at 50
- Helene - Living with MF
- How to Cope
- JoAnn Mason: A Parent's Perspective
- Julie
- Larry
- Lina - ET
- Lorraine
- Mason Fund
- MDS / MPN Spring Rounds
- Midwest MPN Patient Symposium
- Molly - a Patient's Daughter
- MPN News Archives
- MPN Support Group Leaders Meet in Chicago
- New York Patient Symposium 2009
- Past Events
- Patient Stories
- Rob - PV: Just Run With It
- Ron Anderson
- Sarah: On beginnings
- Sixth International Patient Symposium on Myeloproliferative Neoplasms
- Support Groups
- Vivienne
- West Palm Beach Patient Symposium
- William - MF
- MPN Science Report from ASH
- Report from ASH December 2010
- Report from ASH December 2011
- Report from ASH December 2012
- 2009 Grant Announcement
- 2011 MPN Research Foundation
- A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
- After Discovering the JAK2 Mutation: Next Steps in Developing Targeted Treatments for PV, ET and MF
- Al Bolea Memorial Bike Ride
- American Society of Hematology Convention 2009
- Annette DeBow's Trek for a Cure starts this week!
- Announcing Challenge Grant 2011
- ASCO releases videos of experts discussing MPDs
- ASH news on Myeloproliferative Disorders
- ASH press release on blood clot risk prediction model
- Bay Area MPN Symposium 2010
- Bike ride fund-raiser in memory of Belmont cyclist
- Biotech and Pharmaceutical Join the Fight to Fund More MPN Research
- Blood Cancer Awarenss Month: Patients Working Together
- Bloomberg Businessweek addresses the slow progress of drug discovery and cites the MPN Research Foundation
- CDC funds multi-disciplinary research on PV
- Cell Therapeutics Completes Acquisition of Pacritinib a Highly Selective JAK2 Inhibitor
- CeMM Identifies Inherited Susceptibility for a Blood Malignancy
- Cytopia Appoints Study Chairman for JAK2 Clinical Trial
- Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
- Discovery of a new mutation in JAK2V617F negative myelofibrosis patients
- Dr. Laura Michaelis discusses issues for PV and ET with MPN Advocacy and Education International
- Eli Lily announces data for Phase I of JAK2 inhibitor trial
- European journal offers review of current JAK Inhibitors
- Event update - Rounds
- Exelixis Reports Data From Ongoing Phase 1 Study Of XL019 To Treat Myelofibrosis - Update
- EXELIXIS WINNING PHASE I RACE
- Feel the Need - Feed the Cure
- Financial Assistance for MPN Patients
- For Pete's Sake: An MF patient's step-daughter goes after a cure for Myeloproliferative Disorders
- Frankly Speaking About Cancer: MF
- Gene Mutation Predicts Outcome in Blood Disorder
- Geron enrolls first patient in drug study for essential thrombocythemia
- Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
- Governor Pat Quinn Proclaims September 20th as MF Day In Illinois
- Grant Awards
- How thrombocythemia is diagnosed
- I5 weeks after health collapse, coach back in beloved routine
- In Memory of Joyce Niblack
- Incyte approved by FDA for special PV protocol
- Incyte meets goals in Myelofibrosis trial
- Incyte nears the finish line for first FDA approved treatment for myelofibrosis
- Incyte Reaches Agreement with FDA on MF Drug
- Incyte reports positive results of JAK Inhibitor tested in Essential Thrombocythemia and Polycythemia Vera patients
- Incyte Reports Progress in Multiple Clinical Programs and Expands JAK Inhibitor Program
- Incyte to start testing drug in PV patients
- Incyte's Novel JAK Inhibitor Demonstrates Rapid Clinical Benefits in Ongoing Phase I/II Myelofibrosis Study
- Incyte's Selective JAK1 / 2 Inhibitor, INCB18424, Demonstrates Rapid and Durable Clinical Benefits in Myelofibrosis Patients - Data presented at ASH Annual Meeting in San Francisco 2008
- JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
- Jakavi approved in Canada
- Jakavi approved in Europe
- Latest Findings Released in Polycythemia Vera Investigation by the Agency for Toxic Substances and Disease Registry
- Letter from our Vice President of Development
- Letter from the President
- Major grant awarded for leukemia & myelofibrosis
- MDS / MPN Rounds 2011
- MPD Chat archives ASH abstracts
- MPD doctors discuss benefits of 2 JAK2 Inhibitors
- MPD doctors discuss benefits of 2 JAK2 Inhibitors
- MPD Foundation funds research for incurable blood disorders
- MPD Foundation Initiates Relationship with the FDA
- MPD Foundation President, Bob Rosen, attends 2004 ASH Conference in San Diego, California
- MPD Foundation Sponsors New Epidemiology Study
- MPD Foundation Sponsors New Epidemiology Study
- MPD Foundations San Diego Symposium Webcast
- MPD Gene Mutation Discovered!
- MPN Advocacy International
- MPN Clinic - Brought to you by MPN Forum
- MPN Fatigue Project 2013
- MPN Forum Launches
- MPN Research Foundation Initiates Cancer Center Visits
- MPN Research Foundation launches new website
- MPN Research Foundation's San Diego Symposium Brings the Experts to the Patients
- MPN research pays off as new MPN drugs advance to market: a report from ASCO
- Myelofibrosis patient draws strength from celebration
- New Cancer Discovery, Hormone to Blame
- New grant opportunity for Myelofibrosis
- New report from Mayo Clinic
- Newsletter Archive
- Novartis drug
- Novartis enters into partnership with Incyte
- Panobinostat MF Trials Phase I
- Patients push researchers to share data
- Pennsylvanians meeting September 22nd to get educated on PV
- Polycythemia Vera: A Patient's Son Reports
- Questions remain on Pennsylvania PV cluster
- Questions remain on Pennsylvania PV cluster
- Rare cancer in northeast Pa. subject of $5.5 million study
- Rare Disease Day 2012
- Report on JAK2 community screening in Pennsylvania
- Report on JAK2 prevalence among MPD patients in India
- Request for Proposals
- Researchers Advancing Blood Cancer Therapies Receive $42.75 Million in Grants From The Leukemia & Lymphoma Society
- Ruben Mesa discusses research and symposium
- Ruben Mesa's Symptom Assessment Tool Helps Patients with MPN
- Sanofi-Aventis purchases TargeGen, developer of drugs for Myeloproliferative Disorders
- SBio drug shows promise for symptom and spleen reduction for myelofibrosis patients
- SBio granted orphan designation for Myelofibrosis drug
- SBio JAK2 inhibitor clinical trials October 2011
- Seeking patients for familial MPN study
- Selected Abstracts Funded by MPD Foundation 2000-Present, Presented in Chronological Order
- September edition of MPD Life
- September is National Blood Cancer Awareness Month
- Study Links ESAs to Higher Leukemia Risk for Some
- Study on thrombosis risk in women with MPD
- Study published on new prognostic tool
- TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
- The MPD Foundation Grows Awareness and Outreach to the MPD Patient Community
- The year in PV, ET and MF
- Tims Run Maine
- Top Scientists to Receive Prestigious Awards From the American Society of Hematology
- UCSD, TargeGen team-up on blood disease treatment
- UIC joins forces with Harvard, Mayo Clinic to battle bone marrow disorders
- UIC RECEIVES $20 MILLION NCI GRANT TO RESEARCH BLOOD DISORDERS
- United Health Care approves Pegasys for MPN
- University of Utah to Investigate Blood Disorders
- Upcoming: Al Bolea Memorial Ride and Barbeque
- Update on Feel the Need - Feed the Cure
- Update on the MF Challenge Grant Review
- Update on the Pennsylvania Superfund Situation
- Watch the West Palm Beach Patient Symposium Presentations
- What are MPN Research Foundation committees?
- Where our money comes from
- White Paper: Nature, Nurture, or Both?
- Why don't JAK Inhibitors reduce the disease burden in Myelofibrosis?
- Women and MPN - a video by Drs. Michaelis and Mesa
- Women and MPNs
- Work in MPDs illustrates benefit of patient involvement in research priorities
- YM Biosciences meets safety requirements; recruiting more patients
- Annette De Bow Hits the Trail Once Again!
- Spring 2012 - Two Days in New York
- Spring 2012: Patient advocacy: What it is and what role we play
- Spring 2012: Robert Pritzker, in Memorium
- Apply for a Grant
- Current Grants
- Gail Roboz MPN
- Meet Our Researchers
- Meet our Researchers - Wei Tong
- Shaoguang Li
- Types of Research We Fund
- Available Treatments
- Cigna approves Pegasys for PV and ET
- Clinical Trials
- Documentation for Pegasys Appeals Process
- Drug Reimbursement
- Essential Thrombocythemia & Polycythemia Vera Clinical Trials
- History of Off-Label Drug Use
- How one patient persuaded her company to pay for Pegasys
- MPN clinical trials: What you need to know
- Myelofibrosis Clinical Trials
